Cromos Pharma's Moscow office has moved
On 31 August 2011, our Moscow office has moved to:
Building 1, 30 Tsvetnoi Bulvar
Office 101/5, floor 1
Moscow
127051
Russia
Fax number has changed to +7 495 748 02 38. Phone number remains the same (+7 495 661 80 03).
For more information about our office locations please click here.
Data management and Biostatistics solutions to ensure the quality of your data
Cromos Pharma appoints new Business Development Director for Central and Eastern Europe
At Cromos Pharma we are constantly growing and developing expanding our horizons and building our capacity to deliver innovative clinical trials solutions across our global network of operations. Therefore, we are delighted to announce the appointment of Nataliya Artyushenko as our new Business Development Director for Central and Eastern Europe.Reasons to choose Ukraine as the location for your next clinical trial
Ukraine, the eight largest European country by population, is an attractive location for sponsors conducting clinical research for a number of key reasons. Cromos Pharma has been successfully managing clinical trials in Ukraine since 2006. This article looks at just some of the benefits of locating your next study here.
Cromos Pharma charting new territories as it looks east to Uzbekistan
Cromos Pharma is continuously developing and looking to explore new territories when it comes to clinical research. In line with this spirit of discovery, we will be shortly commencing a new project in Uzbekistan supporting a study being conducted by the Swiss Tropical and Public Health Institute.
IWD2021: Championing Women making healthcare breakthroughs
March 8th is International Women’s day, a global day of celebration of the social, political cultural and economic achievements of women. It is also a day for promoting the goal of greater gender parity across all sections of society. At Cromos Pharma, we are using this day to celebrate just a few of the many trailblazing women in healthcare.Cromos CEO outlines advantages of Central and Eastern Europe for clinical trials
Thinking about Eastern Europe as a venue for your clinical trial? Cromos Pharma CEO Vlad Bogin outlines some of the advantages in this new interview.Rare diseases and drug development
The World Economic Forum estimates that 475 million people worldwide are affected by a rare disease. To mark World Rare Disease Day (28 February 2021), in this article Stephanie Finnegan, Cromos Pharma’s COO, explores the opportunities and challenges for rare disease drug development.Key factors to consider for rare disease/orphan drug development
To mark World Rare Disease Day (28th February 2021), Cromos Pharma's Head of Start-Up outlines some of the key factors to consider for rare disease/orphan drug clinical trials.Connect with us at DIA Europe and BIO-Europe this March
Cromos Pharma is delighted to be taking part in the upcoming DIA Europe conference (15 – 19 March 2021) and BIO-Europe Spring (22-25 March 2021).
International Women and Girls in Science Day
February 11th is International Women and Girls in Science Day. A joint UNESCO and UN-Women initiative, it aims to promote the role of #WomenInScience and to challenge some of the barriers to girls pursuing a career in science.
Top 5 reasons to locate your next clinical trial in Hungary
Discover some of the reasons why you should consider Hungary as a location for your next clinical trial.Cromos Pharma offers EU Legal Representative Service
Are you a sponsor seeking to conduct clinical trials in the European Union but do not have a registered office in the European Economic Area? If so, in order to comply with the European Union Clinical Trial Directive, you are required to work with a Legal Representative registered in an EEA country.
World Cancer Day 2021: Cromos Pharma is committed to supporting clinical research to make cancer breakthroughs
Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. World Cancer Day was established in Paris at the first World Cancer Summit in 2000.
Upcoming EU drug/device legislation: What you need to know
Zsolt Kocsis, Cromos Pharma's Head of EU Operations explores some of the upcoming changes to EU legislation in relation to drug development and medical devices.Reaping the benefits of a Euro-Australian collaboration for biotechs: save on costs and time
Cromos Pharma CEO Dr Vlad Bogin is joined by Avance Clinical's CEO Yvonne Lungershausen to discuss some of the benefits available to biotechs by availing of a joint initiative that combines Australian tax benefits for clinical research with exceptional patient recruitment and retention in Eastern European markets.Clinical trials in the time of COVID: Risks, mitigation and lessons learned
Clinical trials: how to enroll on time, stay on budget and not compromise data quality
Stephanie Finnegan, COO of Cromos Pharma delivers key insights into how to maintain study and data integrity when facing cost and time constraints. When time and money is of the essence how can you achieve patient recruitment targets?Global vaccine rollout underway as COVID-19 cases surge
As 2021 begins, many countries are grappling with a renewed surge of COVID-19 infections necessitating further public health restrictions putting more pressure on health systems, societies and global economies. The task of rolling out approved vaccines is increasingly urgent. Almost 16 million doses of COVID-19 vaccines have been administered to date in 37 countries worldwide according to data compiled by Bloomberg ( updated 7 Jan 2021).
JP Morgan Healthcare Conference: Virtual Booth and Daily Presentations
We have been meeting you at the JP Morgan Healthcare Conference for the past 11 years and there is no way we are going to break with this tradition. Meet us at the CROMOS PHARMA VIRTUAL BOOTH January 11th through 14th from 8 am to 5 pm(PST). Learn about some of the most vital issues in clinical research by attending our daily presentations or stop by anytime for a chat.Seasons Greetings from Cromos Pharma
Seasons Greetings from everyone at Cromos Pharma. Watch our holiday video here>>Watch: The benefits of Cromos Pharma and Avance Clinical's biotech initiative
In October we launched an exciting collaboration with Avance Clinical to offer biotechs a scalable clinical trials solution. The collaboration allows biotechs to quickly start their pre-IND early phase studies in Australia, then expand to Central/Eastern Europe to access the large patient populations for their Phase 2 and 3 studies. In this new video you can learn more about the benefits of this initiative.World AIDS Day 2020: Remarkable progress but the fight continues
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
Thanksgiving Greetings
Thanksgiving Greetings from everyone at Cromos Pharma. Watch our video here.World Pancreatic Cancer Awareness Day 2020
Thursday 19 November 2020 is World Pancreatic Cancer Awareness Day. Here at Cromos Pharma we are proud to play our part in supporting clinical trials aimed at finding better treatments for pancreatic cancers.
FDA Offers Guidance to Enhance Diversity in Clinical Trials
The FDA released a statement (9 November 2020) outlining its commitment to promoting greater diversity in medical product development and issuing a new guidance document outlining the agency's thinking on encouraging greater inclusivity “Enhancing the Diversity of Clinical Trial Populations--Eligibility Criteria, Enrollment Practices, and Trial Designs,”Cromos Pharma and Avance Clinical share details of innovative collaboration at BIO-Europe 2020
Cromos Pharma and Avance Clinical announced details of their innovative collaboration to offer biotechs scalable clinical trial solutions at BIO-Europe 2020.Orphan Drugs Market to Reach USD 340.84 Billion by 2027
The global orphan drugs market size is projected to reach USD 340.84 billion by the end of 2027. Increasing number of regulatory approvals will have a positive impact on the growth of the overall market in the coming years according to a new report from Fortune Business Insights.Cromos Pharma and Avance Clinical launch scalable clinical trial solution for biotech
Cromos Pharma is delighted to announce a new collaboration with Avance Clinical providing a scalable clinical trial solution for biotech.Video: Cromos Pharma and Avance Clinical Collaboration
Cromos Pharma and Avance Clinical are joining forces to offer a scalable clinical trial solution for biotechs. Watch the video to find out more>>Alzheimer's Awareness Month: Q&A with Dr Sabina Brennan
September is World Alzheimer’s Month. Alzheimer’s Disease (AD) is the most well-known form of dementia. Dementia is the collective name for progressive brain conditions affecting memory, thinking, behavior and emotions. Dementia affects almost 50 million people worldwide. While aging is a major risk factor for dementia, it also affects people under 65 years. To mark Alzheimer’s Awareness Month (Sept 2020) we sat down with leading psychologist, neuroscientist and best-selling author Dr Sabina Brennan. Dr Brennan is a brain health expert who has advised Irish and UK governments on policies relating to aging and dementia. She is the Irish national representative on the Medical and Scientific Advisory Panel for Alzheimer’s Disease International.Watch Webinar: Where in the world should I locate my pivotal clinical trial?
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.